Wall Street analysts split on Chemours as energy costs shift
The specialty chemicals firm trades at a discount to consensus targets despite diverging views on near-term input costs and long-term technology demand.
Wall Street analysts issued mixed assessments of The Chemours Company in early July 2026, reflecting a divergence between near-term cost headwinds and long-term demand projections for the Wilmington, Delaware-based specialty chemicals producer. The stock was trading approximately 11 per cent below the lowest Wall Street price target of $21 at the time of reporting.
BMO Capital analyst John McNulty reiterated a Buy rating on July 6, setting a price target of $26. This target aligns closely with the median Wall Street consensus of $25, derived from 11 analysts covering the stock. The firm’s stance suggests confidence in the company’s positioning across its Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials segments.
Conversely, Mizuho Securities lowered its price target for the company from $30 to $25 on July 1, while maintaining an Outperform rating. The adjustment was attributed to a decline in oil prices, which Mizuho stated reduced the expected cost advantage of natural gas for basic chemical producers. This shift in energy pricing dynamics represents a key variable for the sector’s profitability.
Despite the downward revision to its price target, Mizuho noted that the adjusted outlook still implied a further 32 per cent upside from current levels. The firm highlighted that sustained investment in advanced computing infrastructure is expected to support long-term demand for technology materials, a segment in which Chemours operates.
The contrasting views underscore the complexity of valuing specialty chemicals firms amidst fluctuating energy markets. While Mizuho focuses on the erosion of natural gas margins, BMO Capital’s higher target reflects a more optimistic view of the company’s growth trajectory relative to the broader market consensus.
